TIVC (TIVC)
Tivic Health Systems, Inc.
NASDAQ:TIVCHealthcare · Medical - Devices
Mkt Cap-
Float-
O/S-
Inst Own-
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
Country
US
USIPO DateNov 11, 2021
Shares Outstanding-
Float--
Company Overview
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company.
Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome.
The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications.
In addition, it offers CDMO services.
The company was incorporated in 2016 and is based in San Antonio, Texas.
Leadership
Christina Valauri
Dean Zikria
Michael K. Handley
Sheryle Bolton
Employees
52
Country
US
Sector
Healthcare
Website
tivichealth.com
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Bolton Sheryle | Director | Purchase | 10.0K | $10.4K | Apr 15, 2026 |
 Valauri Christina Rizopoulos | Director | Purchase | 19.0K | $18.0K | Apr 1, 2026 |
 Wolf Lisa G | COO & CFO | Option Exercise | 92 | -- | Mar 18, 2026 |
| Wolf Lisa G | COO & CFO | Option Exercise | 92 | -- | Mar 18, 2026 |
 Handley Michael K | Chief Operating Officer | Option Exercise | 8.8K | -- | Feb 18, 2026 |
| Handley Michael K | Chief Operating Officer | Option Exercise | 8.8K | -- | Feb 18, 2026 |
Shareholders
--
Institutional
(12)
--
Insiderⓘ
(5)
--
5%+ Owners
(2)
--
Unattributed (incl. retail)ⓘ
Top Shareholders
| Name | Shares | % | Source |
|---|---|---|---|
3i, LP · joint filing· may incl. warrants· filed Sep 2026 | 2.1M | 9.9% | 13D |
Murchinson Ltd. | 115.0K | -- | 13F |
CITADEL ADVISORS LLC | 74.1K | -- | 13F |
Sanctuary Advisors, LLC | 61.2K | -- | 13F |
Marex Group Ltd | 54.3K | -- | 13F |
Virtu Financial LLC | 39.2K | -- | 13F |
 Ernst Jennifer Chief Executive Officer, Director | 32.7K | -- | FORM 4 |
GEODE CAPITAL MANAGEMENT, LLC | 19.4K | -- | 13F |
Mitchell P. Kopin · may incl. warrants· stale · filed May 2024 | 19.1K | 5.0% | 13G |
 Valauri Christina Rizopoulos Director | 19.0K | -- | FORM 4 |
Sources: 13F, Form 4, 13D/13G
Insiders & Institutional Holders
Insiders
- Bolton SheryleDirector
- Valauri Christina RizopoulosDirector
- Wolf Lisa GCOO & CFO
- Handley Michael KChief Operating Officer
- Ernst JenniferChief Executive Officer
- Zikria DeanInterim CEO
- Gurfein BlakeChief Scientific Officer
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
CountryUS
USIPO DateNov 11, 2021
Shares Outstanding-
Float--
52-Week Range
Volume
Average Daily Volume--
30d Avg
--
60d Avg
--
90d Avg
--
Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...